338 related articles for article (PubMed ID: 35189266)
1. Merging data curation and machine learning to improve nanomedicines.
Chen C; Yaari Z; Apfelbaum E; Grodzinski P; Shamay Y; Heller DA
Adv Drug Deliv Rev; 2022 Apr; 183():114172. PubMed ID: 35189266
[TBL] [Abstract][Full Text] [Related]
2. Nanoinformatics for biomedicine: emerging approaches and applications.
Liu X; Webster TJ
Int J Nanomedicine; 2013; 8 Suppl 1(Suppl 1):1-5. PubMed ID: 24101873
[TBL] [Abstract][Full Text] [Related]
3. Artificial intelligence to bring nanomedicine to life.
Serov N; Vinogradov V
Adv Drug Deliv Rev; 2022 May; 184():114194. PubMed ID: 35283223
[TBL] [Abstract][Full Text] [Related]
4. Artificial Intelligence and Machine Learning in Computational Nanotoxicology: Unlocking and Empowering Nanomedicine.
Singh AV; Ansari MHD; Rosenkranz D; Maharjan RS; Kriegel FL; Gandhi K; Kanase A; Singh R; Laux P; Luch A
Adv Healthc Mater; 2020 Sep; 9(17):e1901862. PubMed ID: 32627972
[TBL] [Abstract][Full Text] [Related]
5. Artificial intelligence aids in development of nanomedicines for cancer management.
Tan P; Chen X; Zhang H; Wei Q; Luo K
Semin Cancer Biol; 2023 Feb; 89():61-75. PubMed ID: 36682438
[TBL] [Abstract][Full Text] [Related]
6. Self-driving laboratories: A paradigm shift in nanomedicine development.
Hickman RJ; Bannigan P; Bao Z; Aspuru-Guzik A; Allen C
Matter; 2023 Apr; 6(4):1071-1081. PubMed ID: 37020832
[TBL] [Abstract][Full Text] [Related]
7. Nanoinformatics Revolutionizes Personalized Cancer Therapy.
Sadan T; Cormode DP; Popovtzer R
Trends Cancer; 2018 Jun; 4(6):397-399. PubMed ID: 29860981
[TBL] [Abstract][Full Text] [Related]
8. Construction of a web-based nanomaterial database by big data curation and modeling friendly nanostructure annotations.
Yan X; Sedykh A; Wang W; Yan B; Zhu H
Nat Commun; 2020 May; 11(1):2519. PubMed ID: 32433469
[TBL] [Abstract][Full Text] [Related]
9. Re-envisioning the design of nanomedicines: harnessing automation and artificial intelligence.
Zaslavsky J; Bannigan P; Allen C
Expert Opin Drug Deliv; 2023 Feb; 20(2):241-257. PubMed ID: 36644850
[TBL] [Abstract][Full Text] [Related]
10. The Nanomaterial Data Curation Initiative: A collaborative approach to assessing, evaluating, and advancing the state of the field.
Hendren CO; Powers CM; Hoover MD; Harper SL
Beilstein J Nanotechnol; 2015; 6():1752-62. PubMed ID: 26425427
[TBL] [Abstract][Full Text] [Related]
11. A concise review: the synergy between artificial intelligence and biomedical nanomaterials that empowers nanomedicine.
Hayat H; Nukala A; Nyamira A; Fan J; Wang P
Biomed Mater; 2021 Aug; 16(5):. PubMed ID: 34280907
[TBL] [Abstract][Full Text] [Related]
12. Knowledge Gaps in Generating Cell-Based Drug Delivery Systems and a Possible Meeting with Artificial Intelligence.
Mozafari N; Mozafari N; Dehshahri A; Azadi A
Mol Pharm; 2023 Aug; 20(8):3757-3778. PubMed ID: 37428824
[TBL] [Abstract][Full Text] [Related]
13. Clinical translation of nanomedicine with integrated digital medicine and machine learning interventions.
Ahmad F; Muhmood T
Colloids Surf B Biointerfaces; 2024 Jun; 241():114041. PubMed ID: 38897022
[TBL] [Abstract][Full Text] [Related]
14. Artificial intelligence and machine learning disciplines with the potential to improve the nanotoxicology and nanomedicine fields: a comprehensive review.
Singh AV; Varma M; Laux P; Choudhary S; Datusalia AK; Gupta N; Luch A; Gandhi A; Kulkarni P; Nath B
Arch Toxicol; 2023 Apr; 97(4):963-979. PubMed ID: 36878992
[TBL] [Abstract][Full Text] [Related]
15. Particle Property Characterization and Data Curation for Effective Powder Property Modeling in the Pharmaceutical Industry.
Wadams RC; Akseli I; Albrecht J; Ferreira AP; Gamble JF; Leane M; Thomas S; Schuman Y; Taylor L; Tobyn M
AAPS PharmSciTech; 2022 Oct; 23(8):286. PubMed ID: 36261755
[TBL] [Abstract][Full Text] [Related]
16. Data Analytics Approach for Rational Design of Nanomedicines with Programmable Drug Release.
Mullis AS; Broderick SR; Binnebose AM; Peroutka-Bigus N; Bellaire BH; Rajan K; Narasimhan B
Mol Pharm; 2019 May; 16(5):1917-1928. PubMed ID: 30973741
[TBL] [Abstract][Full Text] [Related]
17. The Role of Machine Learning in Centralized Authorization Process of Nanomedicines in European Union.
Santana R; Onieva E; Zuluaga R; Duardo-Sánchez A; Gañán P
Curr Top Med Chem; 2021; 21(9):828-838. PubMed ID: 33745436
[TBL] [Abstract][Full Text] [Related]
18. Predicting Nanoparticle Delivery to Tumors Using Machine Learning and Artificial Intelligence Approaches.
Lin Z; Chou WC; Cheng YH; He C; Monteiro-Riviere NA; Riviere JE
Int J Nanomedicine; 2022; 17():1365-1379. PubMed ID: 35360005
[TBL] [Abstract][Full Text] [Related]
19. Trends and patterns in cancer nanotechnology research: A survey of NCI's caNanoLab and nanotechnology characterization laboratory.
Ke W; Crist RM; Clogston JD; Stern ST; Dobrovolskaia MA; Grodzinski P; Jensen MA
Adv Drug Deliv Rev; 2022 Dec; 191():114591. PubMed ID: 36332724
[TBL] [Abstract][Full Text] [Related]
20. Orthodontics in the era of big data analytics.
Allareddy V; Rengasamy Venugopalan S; Nalliah RP; Caplin JL; Lee MK; Allareddy V
Orthod Craniofac Res; 2019 May; 22 Suppl 1():8-13. PubMed ID: 31074158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
